IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in IGC Pharma, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +3 vs. Q1 2026
- Shares held
- 5.19M
- +867.3K (+20.0%) vs. Q1 2026
- Total value
- $1.41M
- +$275.0K (+24.2%) vs. Q1 2026
- New holders
- 7
- 6 more added
- Sold out
- 4
- 7 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $1.41M |
| Q1 2026 | 35 | $1.14M |
| Q4 2025 | 30 | $1.36M |
| Q3 2025 | 35 | $2.27M |
| Q2 2025 | 28 | $929.4K |
| Q1 2025 | 25 | $814.9K |
| Q4 2024 | 30 | $954.3K |
| Q3 2024 | 23 | $1.19M |
| Q2 2024 | 25 | $1.11M |
| Q1 2024 | 25 | $943.4K |
| Q4 2023 | 25 | $691.3K |
| Q3 2023 | 27 | $1.01M |
| Q2 2023 | 23 | $827.5K |
| Q1 2023 | 23 | $917.6K |
| Q4 2022 | 26 | $937.3K |
| Q3 2022 | 26 | $1.31M |
| Q2 2022 | 29 | $1.73M |
| Q1 2022 | 29 | $3.97M |
| Q4 2021 | 29 | $6.07M |
| Q3 2021 | 32 | $7.90M |
| Q2 2021 | 29 | $7.90M |
| Q1 2021 | 29 | $7.97M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1 | $0 | 0.00% | −8,096−100.0% | Reduced |
| Triumph Capital Management | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Napier Financial, LLC | 58 | $16 | 0.00% | 00.0% | Unchanged |
| DHJJ Financial Advisors, Ltd. | 80 | $22 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 101 | $27 | 0.00% | 00.0% | Unchanged |
| Hurley Capital, LLC | 100 | $27 | 0.00% | 00.0% | Unchanged |
| Caitlin John, LLC | 200 | $54 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 721 | $196 | 0.00% | +721 | New |
| Rockefeller Capital Management L.P. | 1,000 | $272 | 0.00% | +1,000 | New |
| Group One Trading, L.P. | 2,600 | $707 | 0.00% | −1,162−30.9% | Reduced |
| Geneos Wealth Management Inc. | 3,000 | $810 | 0.00% | 00.0% | Unchanged |
| Burnham & Co LLC | 5,000 | $1.36K | 0.00% | +5,000 | New |
| Wealthcare Advisory Partners LLC | 10,000 | $2.72K | 0.00% | 00.0% | Unchanged |
| Vanguard Global Advisers, LLC | 14,944 | $4.07K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 27,607 | $7.51K | 0.00% | +6,558+31.2% | Added |
| Susquehanna International Group, LLP | 28,882 | $7.86K | 0.00% | −93,713−76.4% | Reduced |
| Commonwealth Equity Services, LLC | 33,348 | $9.07K | 0.00% | −500−1.5% | Reduced |
| Morgan Stanley | 35,198 | $9.57K | 0.00% | +80+0.2% | Added |
| XTX Topco Ltd | 39,378 | $10.7K | 0.00% | −11,270−22.3% | Reduced |
| Fisher Asset Management, LLC | 43,400 | $11.8K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 46,043 | $12.5K | 0.00% | +46,043 | New |
| Truist Financial Corp | 48,667 | $13.2K | 0.00% | +12,000+32.7% | Added |
| Dearborn Partners LLC | 59,401 | $16.2K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 62,610 | $17.0K | 0.00% | +62,610 | New |
| Goldman Sachs Group Inc | 65,541 | $17.8K | 0.00% | 00.0% | Unchanged |
| Lawood & Co | 75,000 | $20.4K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 170,274 | $46.3K | 0.00% | +56,867+50.1% | Added |
| State Street Corp | 200,799 | $54.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 286,608 | $78.0K | 0.00% | −197,367−40.8% | Reduced |
| Vanguard Fiduciary Trust Co | 419,413 | $114.1K | 0.00% | +3,525+0.8% | Added |
| Citadel Advisors LLC | 437,317 | $119.0K | 0.00% | +437,317 | New |
| AdvisorShares Investments LLC | 678,480 | $184.5K | 0.02% | +678,480 | New |
| BlackRock, Inc. | 703,798 | $191.4K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 814,914 | $221.7K | 0.00% | +96,478+13.4% | Added |
| Geode Capital Management, LLC | 879,394 | $239.2K | 0.00% | −163,990−15.7% | Reduced |
| Johnson Financial Group, Inc. | 1 | – | – | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,233−100.0% | Sold out |
| T3 Companies, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Schneider Downs Wealth Management Advisors, LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Trask Adam Roland | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |